TReatment of Irritable Bowel Syndrome With Diarrhoea Using Titrated ONdansetron Trial
Status:
Unknown status
Trial end date:
2020-02-28
Target enrollment:
Participant gender:
Summary
A placebo controlled study to determine the efficacy and mode of action of ondansetron in the
treatment of irritable bowel syndrome with diarrhoea.
Phase:
Phase 3
Details
Lead Sponsor:
University of Leeds
Collaborators:
Barnsley Hospital NHS Foundation Trust Barts & The London NHS Trust County Durham and Darlington NHS Foundation Trust Flinders University London North West Healthcare NHS Trust Lothian Health Board Manchester University NHS Foundation Trust National Institute for Health Research, United Kingdom NHS Lothian Queen Mary University of London Sandwell & West Birmingham Hospitals NHS Trust Sheffield Teaching Hospitals NHS Foundation Trust The Leeds Teaching Hospitals NHS Trust University College London Hospitals University Hospitals of North Midlands NHS Trust University of Manchester